joint pain; severe fatigue; headaches; bone pain (severe); heart palpitions; high blood pressure; vision issues (blurry, dry eye); vision issues (blurry, dry eye); vision issues (blurry, dry eye); cold feet; pain at surgical sites/pain at lymph nodes near surgical site; muscle twitching; severe muscle cramping; pain at surgical sites/pain at lymph nodes near surgical site; The initial case was missing the following minimum criteria: no adverse effect. Upon receipt of follow-up information on (PRD), this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 30Apr2021 11:30 (Lot number: EW070) at the age of 53 years as dose 2, single and intramuscular, administered in arm left, administration date 02Apr2021 11:30 (Lot number: EP7533) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Breast cancer", start date: 03May2015 (ongoing), notes: 2015 Mastectomy; "Osteopenia" (ongoing); "Pulmonary micronodules stable" (ongoing); "Mastectomy", start date: 2015 (unspecified if ongoing). Concomitant medication(s) included: EXEMESTANE taken for cancer hormonal therapy, start date: Apr2015 (ongoing); ASPIRIN 81, start date: Apr2015 (ongoing); ATORVASTATIN taken for blood cholesterol, start date: Oct2015 (ongoing). The following information was reported: FATIGUE (medically significant) with onset 07Apr2021, outcome "not recovered", described as "severe fatigue"; HEADACHE (medically significant) with onset 07Apr2021, outcome "not recovered", described as "headaches"; BONE PAIN (medically significant) with onset 07Apr2021, outcome "not recovered", described as "bone pain (severe)"; ARTHRALGIA (medically significant) with onset 08Apr2021, outcome "not recovered", described as "joint pain"; PALPITATIONS (non-serious) with onset 2021, outcome "recovered" (2021), described as "heart palpitions"; HYPERTENSION (non-serious) with onset 2021, outcome "recovered" (2021), described as "high blood pressure"; VISUAL IMPAIRMENT (non-serious), VISION BLURRED (non-serious), DRY EYE (non-serious) all with onset 2021, outcome "not recovered" and all described as "vision issues (blurry, dry eye)"; PERIPHERAL COLDNESS (non-serious) with onset 2021, outcome "not recovered", described as "cold feet"; PAIN (non-serious), LYMPH NODE PAIN (non-serious) all with onset 2021, outcome "not recovered" and all described as "pain at surgical sites/pain at lymph nodes near surgical site"; MUSCLE TWITCHING (non-serious) with onset 2021, outcome "not recovered", described as "muscle twitching"; MUSCLE SPASMS (non-serious) with onset 2021, outcome "not recovered", described as "severe muscle cramping". The events "severe fatigue", "headaches", "bone pain (severe)" and "joint pain" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2021) negative, notes: weekly  since 01Mar2021. Employer required weekly testing. It was unknown if therapeutic measures were taken as a result of fatigue, headache, bone pain, arthralgia.   Clinical course:Subject: Patient Assistance. Customer Verbatim: I belong to a group that shares information and support for those of us that have developed numerous health issues since receiving the Covid vaccinations. There are so, so many. Why isn't this made available to our gov't? I can't deal w/anymore of these side effects, especially while on cancer treatments. And, now I'll lose my job because I won't get the mandated booster. Not everyone handles this the same & this needs to be preached to our gov't. Please help! Prior Vaccinations and specific relevant tests For Thromboembolic events with Thrombocytopenia was none.   No follow-up attempts are possible. No further information is expected.